SAN DIEGO, June 6, 2012 /PRNewswire via COMTEX/ --
Suneva Medical, a privately-held aesthetics company, has launched
ReGenica Skincare, a three-product breakthrough anti-aging rejuvenation
system, developed by the inventor of the key ingredient in TNS. ReGenica
contains a highly potent, unique variety of proteins and growth factors
in a serum-free solution. It is clinically proven to help reverse the
signs of aging and aid in scarless wound healing. The product is
available only through physician offices.
To view the multimedia assets associated with this release, please click
http://www.prnewswire.com/news-releases/suneva-medical-introduces-regenica-the-next-generation-of-growth-factor-skincare-157356985.html
ReGenica's Multipotent CCM Complex(TM) represents the next generation of
growth factor skincare. The technology was developed by Dr. Gail K.
Naughton, a pioneer in the field of regenerative medicine. Suneva
Medical licensed ReGenica from Histogen Inc. in March 2012, expanding
its portfolio of unique aesthetic products.
"Dr. Naughton is a well renowned regenerative medicine scientist and her
research has helped advance the skincare industry. ReGenica's
groundbreaking technology is both a novel advance and an ideal fit for
our growing portfolio of highly differentiated aesthetic products.
Suneva continues to strive to move into the future by offering our
customers unique aesthetic products proven to help manage the appearance
of aging," commented Nicholas Teti, Chairman and Chief Executive
Officer of Suneva Medical.
ReGenica is not simply another line of products with a promise of
improved aesthetic results. Clinical studies have demonstrated ReGenica
to deliver proven, measurable results in skin rejuvenation. In one
study, ReGenica Advanced Rejuvenation Day Repair SPF 15 & Overnight
Repair have been shown to reduce the appearance of fine lines and
wrinkles, improve skin tone and generate smoother skin over a ten (10)
week period. In two published studies, ReGenica Facial Rejuvenation
Complex Post Procedure has been found to improve healing and more rapid
re-epithelialization as early as three (3) days post procedure.
Mr. Teti continued, "ReGenica is the next generation of regenerative
medicine products and has the potential to change the topical aesthetics
landscape."
0 comments:
Post a Comment